Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Most standard lyophilized research vials are commonly prepared using 2mL of bacteriostatic water unless otherwise specified directly on the product page or vial label
The theoretical risks are minor metabolic shifts (free fatty acid mobilization) and injection-site effects
Retatrutide is an unlicensed investigational peptide in the UK with no MHRA or EMA marketing authorisation as of 2024
Clean the injection site gently with alcohol swab to avoid any kind of infection
Peptide Sequence (IUPAC Condensed): H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.1 g/mol Synonyms: Anti-Obesity Drug 9604 View the AOD-9604 Certificate Of Analysis (COA) View the AOD-9604 High Performance Liquid Chromatography (HPLC) AOD-9604 works by targeting beta-3 adrenergic receptors, which are mostly found in fat tissue
